Real-life data collection for patients with Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) Real-Life Database
This study is collecting information from people with Chronic Myeloid Leukemia to see how different treatments work and how they affect patients over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3500 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 14 sites (Annecy and 13 other locations) |
| Trial ID | NCT05963061 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a large cohort of patients diagnosed with Chronic Myeloid Leukemia (CML) to collect long-term follow-up data. It will gather both prospective and retrospective clinico-biological information to facilitate various observational studies, including epidemiological analyses and treatment response evaluations. The study will also assess the impact of evolving treatment recommendations and the use of new therapeutic agents in real-life settings.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with Chronic Myeloid Leukemia.
Not a fit: Patients who have undergone CML allograft without TKI treatment or those unable to provide consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of CML treatment outcomes and improve patient management strategies.
How similar studies have performed: Other observational studies in hematologic malignancies have shown success in improving treatment strategies and patient outcomes, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient diagnosed for chronic myelocytic leukemia Exclusion Criteria: * CML allograft without TKI treatment * Refusal or inability to sign the consent
Where this trial is running
Annecy and 13 other locations
- CH Annecy Genevois — Annecy, France (Recruiting)
- University Hospital, Caen — Caen, France (Recruiting)
- CHU Clemront-Ferrand — Clermont-Ferrand, France (Recruiting)
- Centre Hospitalier Emile Roux — Le Puy-en-Velay, France (Recruiting)
- University Hospital, Limoges — Limoges, France (Recruiting)
- Institut Paoli-Calmettes — Marseille, France (Recruiting)
- Centre Hospital, Nancy — Nancy, France (Recruiting)
- Bicetre Hospital — Paris, France (Recruiting)
- Hopital Paul Brousse — Paris, France (Recruiting)
- Rennes University Hospital — Rennes, France (Recruiting)
- Centre Hospitalier de Rochefort — Rochefort, France (Recruiting)
- Centre Hospitalier Universitaire de Saint Etienne — Saint-Etienne, France (Recruiting)
- University Hospital, Toulouse — Toulouse, France (Recruiting)
- Versailles Hospital — Versailles, France (Recruiting)
Study contacts
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: 04 73 75 11 95
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.